Palvella Therapeutics, Inc. · NASDAQ:PVLA

BVF PARTNERS L P/IL reported a 7.10% stake in Palvella Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

BVF PARTNERS L P/IL reported a 7.10% stake in Palvella Therapeutics, Inc., 879,009 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
7.10%
Shares
879,009
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P3.80%471,202
BVF I GP LLC3.80%471,202
BIOTECHNOLOGY VALUE FUND II LP2.80%341,883
BVF II GP LLC2.80%341,883
Biotechnology Value Trading Fund OS LP0.40%53,187
BVF Partners OS Ltd.0.40%53,187
BVF GP HOLDINGS LLC6.60%813,085
BVF PARTNERS L P/IL7.10%879,009
BVF INC/IL7.10%879,009
LAMPERT MARK N7.10%879,009

Source

View original at SEC

Related